Bilirubin-JPH203 nanoparticles as well as preparation and application thereof
One-JPH203, JPH203 technology, applied in the field of bilirubin-JPH203 nanoparticles and its preparation and application, can solve the problems of bilirubin and JPH203, and achieve enhanced drug treatment effect, strong operability and industrialization Foreground good effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0036] The preparation of embodiment 1 bilirubin nanoparticles
[0037] According to Table 1, a certain amount of bilirubin and JPH203 were dissolved in 2mL dimethyl sulfoxide to form an organic phase, and then the organic phase was slowly dropped into the water phase, and the stirring was continued for 12 hours; after dialysis to remove the organic solvent, the obtained sample. Record the experimental observations during the preparation.
[0038] Table 1 Preparation points of bilirubin nanoparticles
[0039]
[0040]
[0041] The bilirubin-JPH203 nanoparticles prepared by the present invention are spherical or worm-like, and are between 160 and 200 nm, indicating that under the appropriate drug ratio and suitable preparation conditions, bimolecular self-assembled nanoparticles can be successfully prepared by bilirubin and JPH203. Granules, the experimental preparation method is reasonable and simple.
Embodiment 2
[0042] Example 2 Therapeutic effect of bilirubin-JPH203 nanoparticles on psoriasis in mice
[0043] Psoriasis-like lesions were induced on the back skin of ICR mice by applying imiquimod cream continuously for 7 days, and a mouse psoriasis model was established. On the 8th day of the experiment, symptoms such as redness, swelling, and scales were observed in the psoriatic mice. Different drugs were applied to the back skin of the mice in the corresponding group, and gauze was applied and fixed with a bandage. 2 times a day for 8 consecutive days.
[0044] The administration of each group is as follows:
[0045] Group A: normal saline group
[0046] Group B: bilirubin nanoparticles 1 prepared in Example 1 (bilirubin dose 10 mg / kg, JPH203 dose 8 mg / kg)
[0047] Group C: bilirubin nanoparticles 2 prepared in Example 1 (bilirubin dose 10 mg / kg, JPH203 dose 6 mg / kg)
[0048] Group D: bilirubin nanoparticles 3 prepared in Example 1 (bilirubin dose 10 mg / kg, JPH203 dose 4 mg / kg) ...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


